🇺🇸 FDA
Patent

US 12396974

Ketone ester as a therapeutic treatment of Covid-19 and related viral infections

granted A61KA61K31/047A61K31/19

Quick answer

US patent 12396974 (Ketone ester as a therapeutic treatment of Covid-19 and related viral infections) held by KetoneAid expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
KetoneAid
Grant date
Tue Aug 26 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/047, A61K31/19, A61K31/22, A61K31/23